Modern cardiovascular therapies offer unprecedented opportunities to improve survival and quality of life. Cardiovascular morbidity and mortality have significantly declined, owing in a large part to preventive therapies and technological advances such as coronary revascularization, implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs). Newer therapies like transcatheter aortic valve replacement hold great promise. Nonetheless, cardiovascular disease remains a leading cause of death.
Kirkpatrick JN, Hauptman PJ, Goodlin SJ. Bundling Informed Consent and Advance Care Planning in Chronic Cardiovascular DiseaseWe Need to Talk. JAMA Intern Med. 2015;175(1):5-6. doi:10.1001/jamainternmed.2014.6219